Top compounds associated with response to C18orf21


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.18 0.0006
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA AT13387 CTRPv2 pan-cancer AAC 0.16 0.0007
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.11 0.0008
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0009
mRNA pac-1 CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.12 0.001
mRNA paclitaxel gCSI pan-cancer AAC 0.18 0.001
Download CSV